Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Research and development costs	$ 1,257,027	$ 343,087
Other	17,870	59,018
Net operating losses	6,515,232	3,381,215
Research and development costs	4,051,553	1,762,716
Unvested stock options	447,355	204,380
Research and development tax credits	756,123
Patents	110,700	92,417
Right-of-use assets	38,706	63,563
Gross deferred income tax assets	13,194,566	5,906,396
Less: valuation allowance	(12,631,033)	(5,580,595)
Net deferred income tax asset	563,533	325,801
Accrual to cash		(11,228)
Property and equipment	(563,533)	(314,573)
Gross deferred income tax liabilities	(563,533)	(325,801)
Net deferred tax asset (liability)